Remove DEA Remove Patients Remove Sleep
article thumbnail

5 Medical Cannabis Strains That Can be Used to Treat PTSD

FloridaMarijuana.net

PTSD patients lack the necessary endocannabinoids to fill the receptor sites properly. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the debilitating symptoms of PTSD. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs).

Strains 190
article thumbnail

Sleep Survey Suggests Cannabis Edibles Especially Helpful for Insomnia; 91% of Respondents Said Edibles Improved Sleep

MedicalJane

As a result, research on the health effects of cannabis and cannabinoids has been limited in the United States, leaving patients, healthcare professionals, and policy makers without the necessary proof they need to make sound decisions regarding the use of cannabis as a medicine.

Sleep 95
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis’ REM Sleep-Suppressing Properties Could Prove Useful in Banishing Nightmares

Veriheal

If so, you can consider yourself among the 50%-85% of adults who battle the occasional nightmare during REM sleep. The Sleep Foundation suggests that nightmares in children are most common between the ages of 3 and 6 but usually occur less often with age. The good news is that cannabis could be the tool for a good night’s sleep.

Sleep 98
article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. After receiving a petition three years prior, the DEA finally answered with action, making plans to deschedule [18F]FP-CIT , a controlled substance derived from cocaine.

DEA 98
article thumbnail

The Key Differences Between CBD and THC You Need to Know

United Patients Group

However, the DEA and FDA still consider CBD a drug regulated under the Schedule I classification. The DEA definition of a Schedule 1 substance is : Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Book a consultation today.

THC 130
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51
article thumbnail

CBD: Everything You Need to Know

CannaMD

Cannabinoids (natural and plant-derived) interact with endocannabinoid receptors to regulate appetite, sleep, pain, stress, and more. For example, the DEA considers Schedule I drugs to have a “high potential for abuse and the potential to create severe psychological and/or physical dependence.” CBD Scheduling Rule Change.

CBD 105